Gomis González, M., Busquets Garcia, A., Matute, C., Maldonado, R., Mato, S., & Ozaita Mintegui, A. (2016). Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model.
Citación estilo ChicagoGomis González, Maria, Arnau Busquets Garcia, Carlos Matute, Rafael Maldonado, Susana Mato, y Andrés Ozaita Mintegui. Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. 2016.
Cita MLAGomis González, Maria, et al. Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. 2016.
Precaución: Estas citas no son 100% exactas.